Related references
Note: Only part of the references are listed.Histamine receptors and cancer pharmacology: an update
Noelia A. Massari et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Screening of tumor-associated antigens based on Oncomine database and evaluation of diagnostic value of autoantibodies in lung cancer
Tingting Wang et al.
CLINICAL IMMUNOLOGY (2020)
Novel role of Giα2 in cell migration: Downstream of PI3-kinase-AKT and Rac1 in prostate cancer cells
Silvia Caggia et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Mast Cell-Derived Histamine Regulates Liver Ketogenesis via Oleoylethanolamide Signaling
Alessandra Misto et al.
CELL METABOLISM (2019)
FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma
Zhao-qi Zhang et al.
MOLECULAR ONCOLOGY (2019)
The sphingosine kinase 2 inhibitor ABC294640 displays anti-non-small cell lung cancer activities in vitro and in vivo
Lu Dai et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
EMT: Mechanisms and therapeutic implications
Mohini Singh et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Histamine H3 receptor antagonist OUP-186 attenuates the proliferation of cultured human breast cancer cell lines
Satoshi Tanaka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Agonist-induced activation of histamine H3 receptor signals to extracellular signal-regulated kinases 1 and 2 through PKC-, PLD-, and EGFR-dependent mechanisms
Xiangru Lai et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Histamine H3 receptor activation inhibits dopamine synthesis but not release or uptake in rat nucleus accumbens
Guillermo Aquino-Miranda et al.
NEUROPHARMACOLOGY (2016)
Inhibition of histamine receptor 3 suppresses glioblastoma tumor growth, invasion, and epithelial-to-mesenchymal transition
Jia-Ji Lin et al.
ONCOTARGET (2015)
Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-β1 signalling pathway in non-small cell lung cancer
Wen-Ke Cai et al.
EUROPEAN JOURNAL OF CANCER (2014)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
PTK6 Promotes Cancer Migration and Invasion in Pancreatic Cancer Cells Dependent on ERK Signaling
Hiroaki Ono et al.
PLOS ONE (2014)
Signaling mechanisms of the epithelial-mesenchymal transition
David M. Gonzalez et al.
SCIENCE SIGNALING (2014)
Clobenpropit enhances anti-tumor effect of gemcitabine in pancreatic cancer
Woo Hyun Paik et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Polymorphisms of human histamine receptor H4 gene are associated with breast cancer in Chinese Han population
Gong-Hao He et al.
GENE (2013)
Association between Gαi2 and ELMO1/Dock180 connects chemokine signalling with Rac activation and metastasis
Hongyan Li et al.
NATURE COMMUNICATIONS (2013)
H3 or H4 histamine receptors: That which contributes to suppressing human cholangiocarcinoma progression still remains to be clarified
Gong-Hao He et al.
HEPATOLOGY (2012)
Deletion and Down-Regulation of HRH4 Gene in Gastric Carcinomas: A Potential Correlation with Tumor Progression
Chao Zhang et al.
PLOS ONE (2012)
Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis
Satoshi Watanabe et al.
BMC CANCER (2011)
The H4 Histamine Receptor Agonist, Clobenpropit, Suppresses Human Cholangiocarcinoma Progression by Disruption of Epithelial Mesenchymal Transition and Tumor Metastasis
Fanyin Meng et al.
HEPATOLOGY (2011)
Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction
Jun Hou et al.
PLOS ONE (2010)
Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
Thiruvengadam Arumugam et al.
CANCER RESEARCH (2009)
H3 Histamine Receptor-Mediated Activation of Protein Kinase Cα Inhibits the Growth of Cholangiocarcinoma In vitro and In vivo
Heather Francis et al.
MOLECULAR CANCER RESEARCH (2009)
The role of histamine in human mammary carcinogenesis - H3 and H4 receptors as potential therapeutic targets for breast cancer treatment
Vanina Medina et al.
CANCER BIOLOGY & THERAPY (2008)
Decreased expression of histamine H1 and H4 receptors suggests disturbance of local regulation in human colorectal tumours by histamine
Katalin Boer et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2008)
Autoregulation of McA-RH7777 hepatoma cell proliferation by histamine H3 receptors
E. Davenas et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Histamine in the nervous system
Helmut L. Haas et al.
PHYSIOLOGICAL REVIEWS (2008)
Molecular aspects of the histamine H3 receptor
Gerold Bongers et al.
BIOCHEMICAL PHARMACOLOGY (2007)
TGF-β and epithelial-to-mesenchymal transitions
J Zavadil et al.
ONCOGENE (2005)
Histamine elevates the expression of Ets-1, a protooncogen in human melanoma cell lines through H2 receptor
H Hegyesi et al.
FEBS LETTERS (2005)
Genomics meets histamine receptors: New subtypes, new receptors
LB Hough
MOLECULAR PHARMACOLOGY (2001)
High constitutive activity of native H3 receptors regulates histamine neurons in brain
S Morisset et al.
NATURE (2000)
Share Paper
